Join to View Full Profile
3410 Worth StDallas, TX 75246
Phone+1 214-370-1000
Fax+1 214-370-1202
Dr. McCollum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. A. David McCollum is an oncologist in Dallas, TX and is affiliated with Texas Oncology with his practice located at the Sammons Cancer Center at Baylor University Medical Center. He received his medical degree from the University of Texas Southwestern Medical School and has been in practice 22 years. He is experienced in the management of gastrointestinal cancers, including hepatobiliary cancers. He has 9 publications and over 500 citings.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Texas Southwestern Medical CenterChief Residency, Internal Medicine, 1998 - 1999- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Texas Southwestern Medical SchoolClass of 1995
Certifications & Licensure
TX State Medical License 1996 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Pre-op Rectal ChemoRad +/- Cetuximab Start of enrollment: 2007 Feb 01
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 37 citationsResults of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised ...Donald A. Richards, Darren M. Kocs, Alexander I. Spira, A. David McCollum, Sami Diab
European Journal of Cancer. 2013-09-01 - 17 citationsReferral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.Haskell M. Kirkpatrick, Cristi L. Aitelli, Huanying Qin, Carlos Becerra, Warren E. Lichliter
Clinical Colorectal Cancer. 2010-07-01 - 24 citationsNovel agents for the treatment of adenocarcinoma of the pancreas.R Pamela Mackenzie, A. David McCollum
Expert Review of Anticancer Therapy. 2009-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
